| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |